Rotaviruses

Virus Research

Volumn 190, Issue , 2014, Pages 75-96

  Desselberger, Ulrich ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Immune responses and correlates of protection; Pathogenesis; Prevention by vaccination; Replication cycle; Rotavirus; Structure function studies

Indexed keywords

CELL PROTEIN; STRUCTURAL PROTEIN; VIRUS PROTEIN;

CELL ORGANELLE; CELLULAR IMMUNITY; DIFFERENTIAL DIAGNOSIS; ENDOPLASMIC RETICULUM; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; LABORATORY DIAGNOSIS; MOLECULAR EPIDEMIOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE GENETICS; REVIEW; RNA SYNTHESIS; ROTAVIRUS; ROTAVIRUS INFECTION; VACCINATION; VIRUS CORE; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; HUMANS; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84906090088     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.06.016     Document Type: Review

References (449)

1. Adams W.R., Kraft L.M. Epizootic diarrhea of infant mice: identification of the etiologic agent. Science 1963, 141(July (3578)):359-360.
2. Aiyegbo M.S., Sapparapu G., Spiller B.W., Eli I.M., Williams D.R., Kim R., Lee D.E., Liu T., Li S., Woods V.L., Nannemann D.P., Meiler J., Stewart P.L., Crowe J.E. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS ONE 2013, 8(May (5)):e61101.
3. Aladin F., Einerhand A.W., Bouma J., Bezemer S., Hermans P., Wolvers D., Bellamy K., Frenken L.G., Gray J., Iturriza-Gómara M. In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS ONE 2012, 7(3):e32949.
4. American Academy of Pediatrics Practice parameter: the management of acute gastroenteritis in young children. Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Pediatrics 1996, 97:424-435.
5. Anderson E.J., Rupp A., Shulman S.T., Wang D., Zheng X., Noskin G.A. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children. Pediatrics 2011, 127(February (2)):e264-e270.
6. Anderson E.J., Shippee D.B., Weinrobe M.H., Davila M.D., Katz B.Z., Reddy S., Cuyugan M.G., Lee S.Y., Simons Y.M., Yogev R., Noskin G.A. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin. Infect. Dis. 2013, 56(March (6)):755-760.
7. Angel J., Franco M.A., Greenberg H.B. Rotavirus vaccines: recent developments and future considerations. Nat. Rev. Microbiol. 2007, 5(July (7)):529-539.
8. Angel J., Franco M.A., Greenberg H.B. Rotavirus immune responses and correlates of protection. Curr. Opin. Virol. 2012, 2(August (4)):419-425.
9. Appaiahgari M.B., Glass R., Singh S., Taneja S., Rongsen-Chandola T., Bhandari N., Mishra S., Vrati S. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine 2014, 32(February (6)):651-656.
10. Arista S., Giammanco G.M., De Grazia S., Colomba C., Martella V., Cascio A., Iturriza-Gòmara M. G2 rotavirus infections in an infantile population of the South of Italy: variability of viral strains over time. J. Med. Virol. 2005, 77(December (4)):587-594.
11. Armah G.E., Sow S.O., Breiman R.F., Dallas M.J., Tapia M.D., Feikin D.R., Binka F.N., Steele A.D., Laserson K.F., Ansah N.A., Levine M.M., Lewis K., Coia M.L., Attah-Poku M., Ojwando J., Rivers S.B., Victor J.C., Nyambane G., Hodgson A., Schödel F., Ciarlet M., Neuzil K.M. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(August (9741)):606-614.
12. Arnold M.M., Barro M., Patton J.T. Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain. J. Virol. 2013, 87(September (17)):9813-9821.
13. Arnold M.M., Sen A., Greenberg H.B., Patton J.T. The battle between rotavirus and its host for control of the interferon signaling pathway. PLoS Pathog. 2013, 9(January (1)):e1003064.
14. Arnoldi F., De Lorenzo G., Mano M., Schraner E.M., Wild P., Eichwald C. Burrone OR Rotavirus increases levels of lipidated LC3 supporting accumulation of infectious progeny virus without inducing autophagosome formation. PLoS ONE 2014, 9(April (4)):e95197.
15. Atia A.N., Buchman A.L. Oral rehydration solutions in non-cholera diarrhea: a review. Am. J. Gastroenterol. 2009, 104(October (10)):2596-2604.
16. Ayala-Breton C., Arias M., Espinosa R., Romero P., Arias C.F., López S. Analysis of the kinetics of transcription and replication of the rotavirus genome by RNA interference. J. Virol. 2009, 83(September (17)):8819-8831.
17. Azevedo M.P., Vlasova A.N., Saif L.J. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert Rev. Vaccines 2013, 12(February (2)):169-181.
18. Azevedo M.S., Zhang W., Wen K., Gonzalez A.M., Saif L.J., Yousef A.E., Yuan L. Lactobacillus acidophilus and Lactobacillus reuteri modulate cytokine responses in gnotobiotic pigs infected with human rotavirus. Benef. Microbes 2012, 3(March (1)):33-42.
19. Bagchi P., Bhowmick R., Nandi S., Kant Nayak M., Chawla-Sarkar M. Rotavirus NSP1 inhibits interferon induced non-canonical NFκB activation by interacting with TNF receptor associated factor 2. Virology 2013, 444(September (1-2)):41-44.
20. Ball J.M., Tian P., Zeng C.Q., Morris A.P., Estes M.K. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 1996, 272(April (5258)):101-104.
21. Barro M., Patton J.T. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(March (11)):4114-4119.
22. Barro M., Patton J.T. Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J. Virol. 2007, 81(May (9)):4473-4481.
23. Bastardo J.W., Holmes I.H. Attachment of SA-11 rotavirus to erythrocyte receptors. Infect. Immun. 1980, 29(September (3)):1134-1140.
24. Berkova Z., Crawford S.E., Trugnan G., Yoshimori T., Morris A.P., Estes M.K. Rotavirus NSP4 induces a novel vesicular compartment regulated by calcium and associated with viroplasms. J. Virol. 2006, 80(June (12)):6061-6071.
25. Bernstein D.I., Smith V.E., Sander D.S., Pax K.A., Schiff G.M., Ward R.L. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J. Infect. Dis. 1990, 162(November (5)):1055-1062.
26. Berois M., Sapin C., Erk I., Poncet D., Cohen J. Rotavirus nonstructural protein NSP5 interacts with major core protein VP2. J. Virol. 2003, 77(February (3)):1757-1763.
27. Bhandari N., Rongsen-Chandola T., Bavdekar A., John J., Antony K., Taneja S., Goyal N., Kawade A., Kang G., Rathore S.S., Juvekar S., Muliyil J., Arya A., Shaikh H., Abraham V., Vrati S., Proschan M., Kohberger R., Thiry G., Glass R., Greenberg H.B., Curlin G., Mohan K., Harshavardhan G.V., Prasad S., Rao T.S., Boslego J., Bhan M.K. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014, (March). for the India Rotavirus Vaccine Group, pii:S0140-6736(13)62630-6.
28. Bhowmick R., Halder U.C., Chattopadhyay S., Nayak M.K., Chawla-Sarkar M. Rotavirus-encoded nonstructural protein 1 modulates cellular apoptotic machinery by targeting tumor suppressor protein p53. J. Virol. 2013, 87(June (12)):6840-6850.
29. Bines J.E. Rotavirus vaccines and intussusception risk. Curr. Opin. Gastroenterol. 2005, 21(January (1)):20-25.
30. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973, 2(December (7841)):1281-1283.
31. Blackhall J., Fuentes A., Magnusson G. Genetic stability of a porcine rotavirus RNA segment during repeated plaque isolation. Virology 1996, 225(November (1)):181-190.
32. Blutt S.E., Conner M.E. Rotavirus: to the gut and beyond!. Curr. Opin. Gastroenterol. 2007, 23(January (1)):39-43.
33. Blutt S.E., Conner M.E. The gastrointestinal frontier: IgA and viruses. Front. Immunol. 2013, 4(November):402.
34. Blutt S.E., Miller A.D., Salmon S.L., Metzger D.W., Conner M.E. IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol. 2012, 5(November (6)):712-719.
35. Blutt S.E., Kirkwood C.D., Parreño V., Warfield K.L., Ciarlet M., Estes M.K., Bok K., Bishop R.F., Conner M.E. Rotavirus antigenaemia and viraemia: a common event?. Lancet 2003, 362(November (9394)):1445-1449.
36. Boom J.A., Sahni L.C., Payne D.C., Gautam R., Lyde F., Mijatovic-Rustempasic S., Bowen M.D., Tate J.E., Rench M.A., Gentsch J.R., Parashar U.D., Baker C.J. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J. Infect. Dis. 2012, 206:1275-1279.
37. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Quaye O., Mijatovic-Rustempasic S., Patel M.M., Baker C.J., Parashar U.D. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr. Infect. Dis. J. 2010, 29(December (12)):1133-1135.
38. Boudreaux C.E., Vile D.C., Gilmore B.L., Tanner J.R., Kelly D.F., McDonald S.M. Rotavirus core shell subdomains involved in polymerase encapsidation into virus-like particles. J. Gen. Virol. 2013, 94(August (Pt 8)):1818-1826.
39. Bowman G.D., Nodelman I.M., Levy O., Lin S.L., Tian P., Zamb T.J., Udem S.A., Venkataraghavan B., Schutt C.E. Crystal structure of the oligomerization domain of NSP4 from rotavirus reveals a core metal-binding site. J. Mol. Biol. 2000, 304(December (5)):861-871.
40. Boyce M., Celma C.C., Roy P. Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J. Virol. 2008, 82(September (17)):8339-8348.
41. Brandt C.D., Kim H.W., Rodriguez W.J., Thomas L., Yolken R.H., Arrobio J.O., Kapikian A.Z., Parrott R.H., Chanock R.M. Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J. Clin. Microbiol. 1981, 13(May (5)):976-981.
42. Broome R.L., Vo P.T., Ward R.L., Clark H.F., Greenberg H.B. Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J. Virol. 1993, 67(May (5)):2448-2455.
43. Broquet A.H., Hirata Y., McAllister C.S., Kagnoff M.F. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium. J. Immunol. 2011, 186(February (3)):1618-1626.
44. Bucardo F., Reyes Y., Svensson L., Nordgren J. Predominance of norovirus and sapovirus in nicaragua after implementation of universal rotavirus vaccination. PLoS ONE 2014, 9(May (5)):e98201.
45. Bucardo F., Rippinger C.M., Svensson L., Patton J.T. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. Infect. Genet. Evol. 2012, 12(August (6)):1282-1294.
46. Bugarcic A., Taylor J.A. Rotavirus nonstructural glycoprotein NSP4 is secreted from the apical surfaces of polarized epithelial cells. J. Virol. 2006, 80(December (24)):12343-12349.
47. Burke B., Desselberger U. Rotavirus pathogenicity. Virology 1996, 218(April (2)):299-305.
48. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996, 272(April (5258)):104-107.
49. Buttery J.P., Danchin M.H., Lee K.J., Carlin J.B., McIntyre P.B., Elliott E.J., Booy R., Bines J.E. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011, 29(April (16)):3061-3066. PAEDS/APSU Study Group.
50. Buttery J.P., Lambert S.B., Grimwood K., Nissen M.D., Field E.J., Macartney K.K., Akikusa J.D., Kelly J.J., Kirkwood C.D. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr. Infect. Dis. J. 2011, 30(January (1 Suppl.)):S25-S29.
51. Campagna M., Budini M., Arnoldi F., Desselberger U., Allende J.E., Burrone O.R. Impaired hyperphosphorylation of rotavirus NSP5 in cells depleted of casein kinase 1alpha is associated with the formation of viroplasms with altered morphology and a moderate decrease in virus replication. J. Gen. Virol. 2007, 88(October (Pt 10)):2800-2810.
52. Campagna M., Eichwald C., Vascotto F., Burrone O.R. RNA interference of rotavirus segment 11 mRNA reveals the essential role of NSP5 in the virus replicative cycle. J. Gen. Virol. 2005, 86(May (Pt 5)):1481-1487.
53. Cao D., Barro M., Hoshino Y. Porcine rotavirus bearing an aberrant gene stemming from an intergenic recombination of the NSP2 and NSP5 genes is defective and interfering. J. Virol. 2008, 82(June (12)):6073-6077.
54. Carlin J.B., Macartney K.K., Lee K.J., Quinn H.E., Buttery J., Lopert R., Bines J., McIntyre P.B. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin. Infect. Dis. 2013, 57(November (10)):1427-1434.
55. Withdrawal of rotavirus vaccine recommendation. MMWR. Morb. Mortal. Wkly. Rep. 1999, 48(November (43)):1007. Centers for Disease Control Prevention (CDC).
56. Chacko A.R., Arifullah M., Sastri N.P., Jeyakanthan J., Ueno G., Sekar K., Read R.J., Dodson E.J., Rao D.C., Suguna K. Novel pentameric structure of the diarrhea-inducing region of the rotavirus enterotoxigenic protein NSP4. J. Virol. 2011, 85(December (23)):12721-12732.
57. Charpilienne A., Lepault J., Rey F., Cohen J. Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity. J. Virol. 2002, 76(August (15)):7822-7831.
58. Chattha K.S., Kandasamy S., Vlasova A.N., Saif L.J., Vitamin A. deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model. PLoS ONE 2013, 8(December (12)):e82966.
59. Chattopadhyay S., Basak T., Nayak M.K., Bhardwaj G., Mukherjee A., Bhowmick R., Sengupta S., Chakrabarti O., Chatterjee N.S., Chawla-Sarkar M. Identification of cellular calcium binding protein calmodulin as a regulator of rotavirus A infection during comparative proteomic study. PLoS ONE 2013, 8(2):e56655.
60. Cheung W., Gill M., Esposito A., Kaminski C.F., Courousse N., Chwetzoff S., Trugnan G., Keshavan N., Lever A., Desselberger U. Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J. Virol. 2010, 84(July (13)):6782-6798.
61. Cheuvart B., Neuzil K.M., Steele A.D., Cunliffe N., Madhi S.A., Karkada N., Han H.H., Vinals C. Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine. Hum. Vaccin. Immunother. 2013, 10(November (2)). (Epub ahead of print).
62. Chiarini A., Arista S., Giammanco A., Sinatra A. Rotavirus persistence in cell cultures: selection of resistant cells in the presence of foetal calf serum. J. Gen. Virol. 1983, 64(May (Pt 5)):1101-1110.
63. Chizhikov V., Patton J.T. A four-nucleotide translation enhancer in the 3'-terminal consensus sequence of the nonpolyadenylated mRNAs of rotavirus. RNA 2000, 6(June (6)):814-825.
64. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics 2001, 107(April (4)):613-618. CHOICE Study Group.
65. Ciarlet M., Crawford S.E., Barone C., Bertolotti-Ciarlet A., Ramig R.F., Estes M.K., Conner M.E. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J. Virol. 1998, 72(November (11)):9233-9246.
66. Ciccarelli S., Stolfi I., Caramia G. Management strategies in the treatment of neonatal and pediatric gastroenteritis. Infect. Drug Resist. 2013, 6(October):133-161.
67. Cohen J., Laporte J., Charpilienne A., Scherrer R. Activation of rotavirus RNA polymerase by calcium chelation. Arch. Virol 1979, 60(3-4):177-186.
68. Conner M.E., Zarley C.D., Hu B., Parsons S., Drabinski D., Greiner S., Smith R., Jiang B., Corsaro B., Barniak V., Madore H.P., Crawford S., Estes M.K. Virus-like particles as a rotavirus subunit vaccine. J. Infect. Dis. 1996, 174(September (Suppl. 1)):S88-S92.
69. Contin R., Arnoldi F., Campagna M., Burrone O.R. Rotavirus NSP5 orchestrates recruitment of viroplasmic proteins. J. Gen. Virol. 2010, 91(July (Pt 7)):1782-1793.
70. Contin R., Arnoldi F., Mano M., Burrone O.R. Rotavirus replication requires a functional proteasome for effective assembly of viroplasms. J. Virol. 2011, 85(March (6)):2781-2792.
71. Corrêa N.B., Penna F.J., Lima F.M., Nicoli J.R., Filho L.A. Treatment of acute diarrhea with Saccharomyces boulardii in infants. J. Pediatr. Gastroenterol. Nutr. 2011, 53(November (5)):497-501.
72. Cortese M.M., Immergluck L.C., Held M., Jain S., Chan T., Grizas A.P., Khizer S., Barrett C., Quaye O., Mijatovic-Rustempasic S., Gautam R., Bowen M.D., Moore J., Tate J.E., Parashar U.D., Vázquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013, 132(July (1)):e25-e33.
73. Corthésy B., Benureau Y., Perrier C., Fourgeux C., Parez N., Greenberg H., Schwartz-Cornil I. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J. Virol. 2006, 80(November (21)):10692-10699.
74. Coulson B.S., Grimwood K., Hudson I.L., Barnes G.L., Bishop R.F. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 1992, 30(July (7)):1678-1684.
75. Coulson B.S., Grimwood K., Masendycz P.J., Lund J.S., Mermelstein N., Bishop R.F., Barnes G.L. Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood. J. Clin. Microbiol. 1990, 28(June (6)):1367-1374.
76. Coulson B.S., Londrigan S.L., Lee D.J. Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(May (10)):5389-5394.
77. Cowley D., Donato C.M., Roczo-Farkas S., Kirkwood C.D. Novel G10P[14] rotavirus strain, Northern Territory, Australia. Emerg. Infect. Dis. 2013, 19(August (8)):1324-1327.
78. Crawford S.E., Estes M.K. Viroporin-mediated calcium-activated autophagy. Autophagy 2013, 9(May (5)):797-798.
79. Crawford S.E., Estes M.K., Ciarlet M., Barone C., O'Neal C.M., Cohen J., Conner M.E. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J. Virol. 1999, 73(June (6)):4813-4822.
80. Crawford S.E., Hyser J.M., Utama B., Estes M.K. Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-β signaling is required for rotavirus replication. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(December (50)):E3405-E3413.
81. Crawford S.E., Labbé M., Cohen J., Burroughs M.H., Zhou Y.J., Estes M.K. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J. Virol. 1994, 68(September (9)):5945-5952.
82. Crawford S.E., Mukherjee S.K., Estes M.K., Lawton J.A., Shaw A.L., Ramig R.F., Prasad B.V. Trypsin cleavage stabilizes the rotavirus VP4 spike. J. Virol. 2001, 75(July (13)):6052-6061.
83. Crawford S.E., Utama B., Hyser J.M., Broughman J.R., Estes M.K. Rotavirus exploits lipid metabolism and energy production for replication. American Society for Virology Annual Meeting 2013, Abstracts; p. 74 (W2-6).
84. Criglar J., Greenberg H.B., Estes M.K., Ramig R.F. Reconciliation of rotavirus temperature-sensitive mutant collections and assignment of reassortment groups D, J, and K to genome segments. J. Virol. 2011, 85(May (10)):5048-5060.
85. Criglar J.M., Hu L., Crawford S.E., Hyser J.M., Broughman J.R., Prasad B.V., Estes M.K. A novel form of rotavirus NSP2 and phosphorylation-dependent NSP2-NSP5 interactions are associated with viroplasm assembly. J. Virol. 2014, 88(January (2)):786-798.
86. da Silva M.F., Tort L.F., Goméz M.M., Assis R.M., Volotão Ede M., de Mendonça M.C., Bello G., Leite J.P. VP7 gene of human rotavirus A genotype G5: phylogenetic analysis reveals the existence of three different lineages worldwide. J. Med. Virol. 2011, 83(February (2)):357-366.
87. Deal E.M., Lahl K., Narváez C.F., Butcher E.C., Greenberg H.B. Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J. Clin. Invest. 2013, 123(June (6)):2464-2474.
88. De Grazia S., Bonura F., Colomba C., Cascio A., Di Bernardo F., Collura A., Terranova D.M., Martella V., Giammanco G.M. Data mining from a 27-years rotavirus surveillance in Palermo, Italy. Infect. Genet. Evol. 2014, (March). pii:S1567-1348(14)00083-5.
89. De Lorenzo G., Eichwald C., Schraner E.M., Nicolin V., Bortul R., Mano M., Burrone O.R., Arnoldi F. Production of in vivo-biotinylated rotavirus particles. J. Gen. Virol. 2012, 93(7):1474-1482.
90. Delmas O., Breton M., Sapin C., Le Bivic A., Colard O., Trugnan G. Heterogeneity of Raft-type membrane microdomains associated with VP4, the rotavirus spike protein, in Caco-2 and MA 104 cells. J. Virol. 2007, 81(February (4)):1610-1618.
91. Dennehy P.H. Treatment and prevention of rotavirus infection in children. Curr. Infect. Dis. Rep. 2013, 15(June (3)):242-250.
92. Dennehy P.H., Cortese M.M., Bégué R.E., Jaeger J.L., Roberts N.E., Zhang R., Rhodes P., Gentsch J., Ward R., Bernstein D.I., Vitek C., Bresee J.S., Staat M.A. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr. Infect. Dis. J. 2006, 25(December (12)):1123-1131.
93. Desai R., Curns A.T., Steiner C.A., Tate J.E., Patel M.M., Parashar U.D. All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009. Clin. Infect. Dis. 2012, 55(August (4)):e28-e34.
94. Desselberger U. Genome rearrangements of rotaviruses. Adv. Virus Res. 1996, 46:69-95.
95. Desselberger U. Prospects for vaccines against rotaviruses. Rev. Med. Virol. 1998, 8(January (1)):43-52.
96. Desselberger U. Rotavirus infections: guidelines for treatment and prevention. Drugs 1999, 58(September (3)):447-452.
97. Desselberger U., Gray J. Viral gastroenteritis. Medicine (Baltimore). 2013, 41(12):700-704.
98. Desselberger U., Huppertz H.I. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J. Infect. Dis. 2011, 203(January (2)):188-195.
99. Desselberger U., Richards J., Tchertanov L., Lepault J., Lever A., Burrone O., Cohen J. Further characterisation of rotavirus cores: ss(+)RNAs can be packaged in vitro but packaging lacks sequence specificity. Virus Res. 2013, 178(December (2)):252-263.
100. Díaz-Salinas M.A., Silva-Ayala D., López S., Arias C.F. Rotaviruses reach late endosomes and require the cation-dependent mannose-6-phosphate receptor and the activity of cathepsin proteases to enter the cell. J. Virol. 2014, (February). (Epub ahead of print).
101. ® vaccine during the 2010-2011 surveillance period. Infect. Genet. Evol. 2014, (May). pii:S1567-1348(14)00189-0 (Epub ahead of print). 10.1016/j.meegid.2014.05.020.
102. Donker N.C., Boniface K., Kirkwood C.D. Phylogenetic analysis of rotavirus A NSP2 gene sequences and evidence of intragenic recombination. Infect. Genet. Evol. 2011, 11(October (7)):1602-1607.
103. Dormitzer P.R., Sun Z.Y., Blixt O., Paulson J.C., Wagner G., Harrison S.C. Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core. J. Virol. 2002, 76(October (20)):10512-10517.
104. Dormitzer P.R., Sun Z.Y., Wagner G., Harrison S.C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 2002, 21(March (5)):885-897.
105. Dubin G., Toussaint J.F., Cassart J.P., Howe B., Boyce D., Friedland L., Abu-Elyazeed R., Poncelet S., Han H.H., Debrus S. Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix™: approach and outcome. Hum. Vaccin. Immunother. 2013, 9(August (11)). (Epub ahead of print).
106. Ebina T. Prophylaxis of rotavirus gastroenteritis using immunoglobulin. Arch. Virol. Suppl. 1996, 12:217-223.
107. Eichwald C., Arnoldi F., Laimbacher A.S., Schraner E.M., Fraefel C., Wild P., Burrone O.R., Ackermann M. Rotavirus viroplasm fusion and perinuclear localization are dynamic processes requiring stabilized microtubules. PLoS ONE 2012, 7(10):e47947.
108. Eichwald C., Rodriguez J.F., Burrone O.R. Characterization of rotavirus NSP2/NSP5 interactions and the dynamics of viroplasm formation. J. Gen. Virol. 2004, 85(March (Pt 3)):625-634.
109. ®. Hum. Vaccin. Immunother. 2014, 10(January (1)):25-32.
110. Esposito D.H., Holman R.C., Haberling D.L., Tate J.E., Podewils L.J., Glass R.I., Parashar U. Baseline estimates of diarrhea-associated mortality among United States children before rotavirus vaccine introduction. Pediatr. Infect. Dis. J. 2011, 30(November (11)):942-947.
111. Essere B., Yver M., Gavazzi C., Terrier O., Isel C., Fournier E., Giroux F., Textoris J., Julien T., Socratous C., Rosa-Calatrava M., Lina B., Marquet R., Moules V. Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(October (40)):E3840-E3848.
112. Estes M.K., Atmar R.L. Viral pathogens in the intestine. Microbial Pathogenesis and the Intestinal Epithelial Cell 2003, 525-545. ASM Press, Washington, DC. G. Hecht (Ed.).
113. Estes M.K., Graham D.Y. Establishment of rotavirus persistent infection in cell culture. Arch. Virol 1980, 65(2):187-192.
114. Estes M.K., Graham D.Y., Smith E.M., Gerba C.P. Rotavirus stability and inactivation. J. Gen. Virol. 1979, 43(May (2)):403-409.
115. Estes M.K., Greenberg H.B. Rotaviruses. Fields Virology 2013, 1347-1401. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA. 6th ed. D.M. Knipe, P.M. Howley (Eds.).
116. Estes M.K., Graham D.Y., Mason B.B. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 1981, 39(September (3)):879-888.
117. Estes M.K., Morris A.P. A viral enterotoxin. A new mechanism of virus-induced pathogenesis. Adv. Exp. Med. Biol. 1999, 473:73-82.
118. Estrozi L.F., Settembre E.C., Goret G., McClain B., Zhang X., Chen J.Z., Grigorieff N., Harrison S.C. Location of the dsRNA-dependent polymerase, VP1, in rotavirus particles. J. Mol. Biol. 2013, 425(January (1)):124-132.
119. Fabbretti E., Afrikanova I., Vascotto F., Burrone O.R. Two non-structural rotavirus proteins, NSP2 and NSP5, form viroplasm-like structures in vivo. J. Gen. Virol. 1999, 80(February (Pt 2)):333-339.
120. Fang S.B., Lee H.C., Hu J.J., Hou S.Y., Liu H.L., Fang H.W. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J. Trop. Pediatr. 2009, 55(October (5)):297-301.
121. Fenaux M., Cuadras M.A., Feng N., Jaimes M., Greenberg H.B. Extraintestinal spread and replication of a homologous EC rotavirus strain and a heterologous rhesus rotavirus in BALB/c mice. J. Virol. 2006, 80(June (11)):5219-5232.
122. Feng N., Franco M.A., Greenberg H.B. Murine model of rotavirus infection. Adv. Exp. Med. Biol. 1997, 412:233-240.
123. Feng N., Kim B., Fenaux M., Nguyen H., Vo P., Omary M.B., Greenberg H.B. Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J. Virol. 2008, 82(August (15)):7578-7590.
124. Feng N., Lawton J.A., Gilbert J., Kuklin N., Vo P., Prasad B.V., Greenberg H.B. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J. Clin. Invest. 2002, 109(May (9)):1203-1213.
125. Feng N., Sen A., Nguyen H., Vo P., Hoshino Y., Deal E.M., Greenberg H.B. Variation in antagonism of the interferon response to rotavirus NSP1 results in differential infectivity in mouse embryonic fibroblasts. J. Virol. 2009, 83(July (14)):6987-6994.
126. Feng N., Sen A., Wolf M., Vo P., Hoshino Y., Greenberg H.B. Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract. J. Virol. 2011, 85(March (6)):2686-2694.
127. Feng N., Yasukawa L.L., Sen A., Greenberg H.B. Permissive replication of homologous murine rotavirus in the mouse intestine is primarily regulated by VP4 and NSP1. J. Virol. 2013, 87(August (15)):8307-8316.
128. Finkbeiner S.R., Allred A.F., Tarr P.I., Klein E.J., Kirkwood C.D., Wang D. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog. 2008, 4(February (2)):e1000011.
129. Finkbeiner S.R., Zeng X.L., Utama B., Atmar R.L., Shroyer N.F., Estes M.K. Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio 2012, 3(July (4)):e00159-e212.
130. Fiore L., Greenberg H.B., Mackow E.R. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 1991, 181(April (2)):553-563.
131. Fischer T.K., Gentsch J.R. Rotavirus typing methods and algorithms. Rev. Med. Virol. 2004, 14(March-April (2)):71-82.
132. Fischer T.K., Viboud C., Parashar U., Malek M., Steiner C., Glass R., Simonsen L. Hospitalizations and deaths from diarrhea and rotavirus among children of <5 years of age in the United States, 1993-2003. J. Infect. Dis. 2007, 195(April (8)):1117-1125.
133. Fleming F.E., Böhm R., Dang V.T., Holloway G., Haselhorst T., Madge P.D., Deveryshetty J., Yu X., Blanchard H., von Itzstein M., Coulson B.S. Relative roles of GM1 ganglioside, N-acylneuraminic acids and α2β1 integrin in mediating rotavirus infection. J. Virol. 2014, (February). (Epub ahead of print).
134. Flewett T.H., Bryden A.S., Davies H. Virus particles in gastroenteritis. Lancet 1973, 2(December (7844)):1497.
135. Flewett T.H., Bryden A.S., Davies H., Woode G.N., Bridger J.C., Derrick J.M. Relation between viruses from acute gastroenteritis of children and newborn calves. Lancet 1974, 2(July (7872)):61-63.
136. Franco M.A., Angel J., Greenberg H.B. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006, 24(April (15)):2718-2731.
137. Franco M.A., Greenberg H.B. Immunity to rotavirus in T cell deficient mice. Virology 1997, 238(November (2)):169-179.
138. Garaicoechea L., Olichon A., Marcoppido G., Wigdorovitz A., Mozgovoj M., Saif L., Surrey T., Parreño V. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J. Virol. 2008, 82(October (19)):9753-9764.
139. Gardet A., Breton M., Fontanges P., Trugnan G., Chwetzoff S. Rotavirus spike protein VP4 binds to and remodels actin bundles of the epithelial brush border into actin bodies. J. Virol. 2006, 80(April (8)):3947-3956.
140. Gastañaduy P.A., Curns A.T., Parashar U.D., Lopman B.A. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA 2013, 310(August (8)):851-853.
141. Gaunt E.R., Cheung W., Richards J.E., Lever A., Desselberger U. Inhibition of rotavirus replication by downregulation of fatty acid synthesis. J. Gen. Virol. 2013, 94(June (Pt 6)):1310-1317. Erratum in: J. Gen. Virol., 2013, 94 (September (Pt 9)), 2140.
142. Gaunt E.R., Zhang Q., Cheung W., Wakelam M.J., Lever A.M., Desselberger U. Lipidome analysis of rotavirus-infected cells confirms the close interaction of lipid droplets with viroplasms. J. Gen. Virol. 2013, 94(July (Pt 7)):1576-1586.
143. Ge Y., Mansell A., Ussher J.E., Brooks A.E., Manning K., Wang C.J., Taylor J.A. Rotavirus NSP4 triggers secretion of proinflammatory cytokines from macrophages via Toll-like receptor 2. J. Virol. 2013, 87(October (20)):11160-11167.
144. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992, 30(June (6)):1365-1373.
145. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., Jain V., Cunliffe N.A., Nakagomi O., Kirkwood C.D., Fischer T.K., Parashar U.D., Bresee J.S., Jiang B., Glass R.I. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 2005, 192(September (Suppl. 1)):S146-S159.
146. Georges-Courbot M.C., Monges J., Siopathis M.R., Roungou J.B., Gresenguet G., Bellec L., Bouquety J.C., Lanckriet C., Cadoz M., Hessel L., et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res. Virol. 1991, 142(September-October (5)):405-411.
147. Giaquinto C., Dominiak-Felden G., Van Damme P., Myint T.T., Maldonado Y.A., Spoulou V., Mast T.C., Staat M.A. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries. Hum. Vaccin. 2011, 7(July (7)):734-748.
148. Gilger M.A., Matson D.O., Conner M.E., Rosenblatt H.M., Finegold M.J., Estes M.K. Extraintestinal rotavirus infections in children with immunodeficiency. J. Pediatr. 1992, 120(June (6)):912-917.
149. Glass R.I., Bresee J.S., Parashar U.D., Jiang B., Gentsch J. The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet 2004, 363(May (9420)):1547-1550.
150. Glass R.I., Parashar U.D. Rotavirus vaccines - balancing intussusception risks and health benefits. N. Engl. J. Med. 2014, 370(February (6)):568-570.
151. Glass R.I., Parashar U., Patel M., Gentsch J., Jiang B. Rotavirus vaccines: successes and challenges. J. Infect. 2014, 68(January (Suppl. 1)):S9-S18.
152. Gleizes O., Desselberger U., Tatochenko V., Rodrigo C., Salman N., Mezner Z., Giaquinto C., Grimprel E. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr. Infect. Dis. J. 2006, 25(January (1 Suppl.)):S12-S21.
153. Gómara M.I., Green J., Gray J. Methods of rotavirus detection, sero- and genotyping, sequencing, and phylogenetic analysis. Methods Mol. Med. 2000, 34:189-216.
154. González A.M., Azevedo M.S., Jung K., Vlasova A., Zhang W., Saif L.J. Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model. Immunology 2010, 131(October (2)):242-256.
155. Gonzalez A.M., Jaimes M.C., Cajiao I., Rojas O.L., Cohen J., Pothier P., Kohli E., Butcher E.C., Greenberg H.B., Angel J., Franco M.A. Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha4beta7. Virology 2003, 305(January (1)):93-105.
156. González R.A., Espinosa R., Romero P., López S., Arias C.F. Relative localization of viroplasmic and endoplasmic reticulum-resident rotavirus proteins in infected cells. Arch. Virol. 2000, 145(9):1963-1973.
157. Gouet P., Diprose J.M., Grimes J.M., Malby R., Burroughs J.N., Zientara S., Stuart D.I., Mertens P.P. The highly ordered double-stranded RNA genome of bluetongue virus revealed by crystallography. Cell 1999, 97(May (4)):481-490.
158. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., Fang Z.Y. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J. Clin. Microbiol. 1990, 28(February (2)):276-282.
159. Graff J.W., Ettayebi K., Hardy M.E. Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism. PLoS Pathog. 2009, 5(January (1)):e1000280.
160. Graff J.W., Ewen J., Ettayebi K., Hardy M.E. Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J. Gen. Virol. 2007, 88(February (Pt 2)):613-620.
161. Graff J.W., Mitzel D.N., Weisend C.M., Flenniken M.L., Hardy M.E. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J. Virol. 2002, 76(September (18)):9545-9550.
162. Graham D.Y., Dufour G.R., Estes M.K. Minimal infective dose of rotavirus. Arch. Virol 1987, 92(3-4):261-271.
163. Graham K.L., Halasz P., Tan Y., Hewish M.J., Takada Y., Mackow E.R., Robinson M.K., Coulson B.S. Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J. Virol. 2003, 77(September (18)):9969-9978.
164. Grandy G., Medina M., Soria R., Terán C.G., Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect. Dis. 2010, 10(August):253.
165. Greenberg H.B. Rotavirus vaccination and intussusception - act two. N. Engl. J. Med. 2011, 364(June (24)):2354-2355.
166. Greenberg H.B., Estes M.K. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009, 136(May (6)):1939-1951.
167. Groft C.M., Burley S.K. Recognition of eIF4G by rotavirus NSP3 reveals a basis for mRNA circularization. Mol. Cell 2002, 9(June (6)):1273-1283.
168. Guarino A., Dupont C., Gorelov A.V., Gottrand F., Lee J.K., Lin Z., Lo Vecchio A., Nguyen T.D., Salazar-Lindo E. The management of acute diarrhea in children in developed and developing areas: from evidence base to clinical practice. Expert Opin. Pharmacother. 2012, 13(January (1)):17-26.
169. Guerrero C.A., Bouyssounade D., Zárate S., Isa P., López T., Espinosa R., Romero P., Méndez E., López S., Arias C.F. Heat shock cognate protein 70 is involved in rotavirus cell entry. J. Virol. 2002, 76(April (8)):4096-4102.
170. Guo C.T., Nakagomi O., Mochizuki M., Ishida H., Kiso M., Ohta Y., Suzuki T., Miyamoto D., Hidari K.I., Suzuki Y. Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J. Biochem. 1999, 126(October (4)):683-688.
171. Gutiérrez M., Isa P., Sánchez-San Martin C., Pérez-Vargas J., Espinosa R., Arias C.F., López S. Different rotavirus strains enter MA104 cells through different endocytic pathways: the role of clathrin-mediated endocytosis. J. Virol. 2010, 84(September (18)):9161-9169.
172. Haber P., Chen R.T., Zanardi L.R., Mootrey G.T., English R., Braun M.M. VAERS Working Group, An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?. Pediatrics 2004, 113(April (4)):e353-e359.
173. Haber P., Patel M., Pan Y., Baggs J., Haber M., Museru O., Yue X., Lewis P., Destefano F., Parashar U.D. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics 2013, 131(June (6)):1042-1049.
174. Hagbom M., Istrate C., Engblom D., Karlsson T., Rodriguez-Diaz J., Buesa J., Taylor J.A., Loitto V.M., Magnusson K.E., Ahlman H., Lundgren O., Svensson L. Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathog. 2011, 7(July (7)):e1002115.
175. Hagbom M., Sharma S., Lundgren O., Svensson L. Towards a human rotavirus disease model. Curr. Opin. Virol. 2012, 2(August (4)):408-418.
176. Harb M., Becker M.M., Vitour D., Baron C.H., Vende P., Brown S.C., Bolte S., Arold S.T., Poncet D. Nuclear localization of cytoplasmic poly(A)-binding protein upon rotavirus infection involves the interaction of NSP3 with eIF4G and RoXaN. J. Virol. 2008, 82(November (22)):11283-11293.
177. Haselhorst T., Fleming F.E., Dyason J.C., Hartnell R.D., Yu X., Holloway G., Santegoets K., Kiefel M.J., Blanchard H., Coulson B.S., von Itzstein M. Sialic acid dependence in rotavirus host cell invasion. Nat. Chem. Biol. 2009, 5(February (2)):91-93.
178. He B., Yang F., Yang W., Zhang Y., Feng Y., Zhou J., Xie J., Feng Y., Bao X., Guo H., Li Y., Xia L., Li N., Matthijnssens J., Zhang H., Tu C. Characterization of a novel G3P[3] rotavirus isolated from a lesser horseshoe bat: a distant relative of feline/canine rotaviruses. J. Virol. 2013, 87(November (22)):12357-12366.
179. Hemming M., Räsänen S., Huhti L., Paloniemi M., Salminen M., Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur. J. Pediatr. 2013, 172(June (6)):739-746.
180. ® vaccine. Infect. Genet. Evol. 2013, 19(October):51-58.
181. ® vaccine-derived double reassortant rotavirus in a 7-year-old child with acute gastroenteritis. Pediatr. Infect. Dis. J. 2013, (December). (Epub ahead of print).
182. Herrmann J.E., Chen S.C., Fynan E.F., Santoro J.C., Greenberg H.B., Wang S., Robinson H.L. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 1996, 174(September (Suppl. 1)):S93-S97.
183. Hertel P.M., Crawford S.E., Bessard B.C., Estes M.K. Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles. Vaccine 2013, 31(November (48)):5778-5784.
184. Holloway G., Coulson B.S. Innate cellular responses to rotavirus infection. J. Gen. Virol. 2013, 94(June (Pt 6)):1151-1160.
185. Holloway G., Dang V.T., Jans D.A., Coulson B.S. Rotavirus inhibits interferon-induced STAT nuclear translocation by a mechanism that acts after STAT binding to importin-α. J. Gen. Virol. 2014, (May). (Epub ahead of print). 10.1099/vir.0.064063-0.
186. Holloway G., Truong T.T., Coulson B.S. Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB. J. Virol. 2009, 83(May (10)):4942-4951.
187. Hou Z., Huang Y., Huan Y., Pang W., Meng M., Wang P., Yang M., Jiang L., Cao X., Wu K.K. Anti-NSP4 antibody can block rotavirus-induced diarrhea in mice. J. Pediatr. Gastroenterol. Nutr. 2008, 46(April (4)):376-385.
188. Hrdy D.B. Epidemiology of rotaviral infection in adults. Rev. Infect. Dis. 1987, 9(May-June (3)):461-469.
189. Hu L., Crawford S.E., Czako R., Cortes-Penfield N.W., Smith D.F., Le Pendu J., Estes M.K., Prasad B.V. Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 2012, 485(April (7397)):256-259.
190. Huang P., Xia M., Tan M., Zhong W., Wei C., Wang L., Morrow A., Jiang X. Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J. Virol. 2012, 86(May (9)):4833-4843.
191. Hundley F., Biryahwaho B., Gow M., Desselberger U. Genome rearrangements of bovine rotavirus after serial passage at high multiplicity of infection. Virology 1985, 143(May (1)):88-103.
192. Hundley F., McIntyre M., Clark B., Beards G., Wood D., Chrystie I., Desselberger U. Heterogeneity of genome rearrangements in rotaviruses isolated from a chronically infected immunodeficient child. J. Virol. 1987, 61(November (11)):3365-3372.
193. Hung T., Chen G.M., Wang C.G., Yao H.L., Fang Z.Y., Chao T.X., Chou Z.Y., Ye W., Chang X.J., Den S.S., et al. Waterborne outbreak of rotavirus diarrhoea in adults in China caused by a novel rotavirus. Lancet 1984, 1(May (8387)):1139-1142.
194. Hung T., Chen G.M., Wang C.G., Chou Z.Y., Chao T.X., Ye W.W., Yao H.L., Meng K.H. Rotavirus-like agent in adult non-bacterial diarrhoea in China. Lancet 1983, 2(November (8358)):1078-1079.
195. Hyser J.M., Collinson-Pautz M.R., Utama B., Estes M.K. Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. MBio 2010, 1(November (5)):e00265-e00310.
196. Hyser J.M., Utama B., Crawford S.E., Broughman J.R., Estes M.K. Activation of the endoplasmic reticulum calcium sensor STIM1 and store-operated calcium entry by rotavirus requires NSP4 viroporin activity. J. Virol. 2013, 87(December (24)):13579-13588.
197. Hyser J.M., Utama B., Crawford S.E., Estes M.K. Genetic divergence of rotavirus nonstructural protein 4 results in distinct serogroup-specific viroporin activity and intracellular punctate structure morphologies. J. Virol. 2012, 86(May (9)):4921-4934.
198. Ianiro G., Heylen E., Delogu R., Zeller M., Matthijnssens J., Ruggeri F.M., Van Ranst M., Fiore L. Genetic diversity of G9P[8] rotavirus strains circulating in Italy in 2007 and 2010 as determined by whole genome sequencing. Infect. Genet. Evol. 2013, 16(June):426-432.
199. Imbert-Marcille B.M., Barbé L., Dupé M., Le Moullac-Vaidye B., Besse B., Peltier C., Ruvoën-Clouet N., Le Pendu J. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J. Infect. Dis. 2014, 209(April (8)):1227-1230.
200. Isa P., Arias C.F., López S. Role of sialic acids in rotavirus infection. Glycoconj. J. 2006, 23(February (1-2)):27-37.
201. Isa P., Realpe M., Romero P., López S., Arias C.F. Rotavirus RRV associates with lipid membrane microdomains during cell entry. Virology 2004, 322(May (2)):370-381. Erratum in: Virology, 2004, 328 (October (1)), 158.
202. Iturriza-Gómara M., Dallman T., Bányai K., Böttiger B., Buesa J., Diedrich S., Fiore L., Johansen K., Koopmans M., Korsun N., Koukou D., Kroneman A., László B., Lappalainen M., Maunula L., Marques A.M., Matthijnssens J., Midgley S., Mladenova Z., Nawaz S., Poljsak-Prijatelj M., Pothier P., Ruggeri F.M., Sanchez-Fauquier A., Steyer A., Sidaraviciute-Ivaskeviciene I., Syriopoulou V., Tran A.N., Usonis V., VAN Ranst M., DE Rougemont A., Gray J. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol. Infect. 2011, 139(June (6)):895-909.
203. Iturriza-Gomara M., Desselberger U., Gray J. Molecular epidemiology of rotaviruses: genetic mechanisms associated with diversity. Viral Gastroenteritis 2003, 317-344. Elsevier Science, Amsterdam. U. Desselberger, J. Gray (Eds.).
204. Iturriza-Gómara M., Green J., Brown D.W., Desselberger U., Gray J.J. Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J. Clin. Microbiol. 2000, 38(February (2)):898-901.
205. Iturriza-Gómara M., Isherwood B., Desselberger U., Gray J. Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999. J. Virol. 2001, 75(April (8)):3696-3705.
206. Iturriza-Gómara M., Kang G., Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J. Clin. Virol. 2004, 31(December (4)):259-265.
207. Jayaram H., Estes M.K., Prasad B.V. Emerging themes in rotavirus cell entry, genome organization, transcription and replication. Virus Res. 2004, 101(April (1)):67-81.
208. ® pyrosequencing reveals evidence of intergenotype genome segment recombination. Infect. Genet. Evol. 2011, 11(December (8)):2072-2082.
209. Jiang B., Gentsch J.R., Glass R.I. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin. Infect. Dis. 2002, 34(May (10)):1351-1361.
210. Jiang B., Gentsch J.R., Glass R.I. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine 2008, 26(December (52)):6754-6758.
211. Jiang B., Wang Y., Glass R.I. Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies. Hum. Vaccin. Immunother. 2013, 9(August (8)):1634-1637.
212. Jiang S., Ji S., Tang Q., Cui X., Yang H., Kan B., Gao S. Molecular characterization of a novel adult diarrhoea rotavirus strain J19 isolated in China and its significance for the evolution and origin of group B rotaviruses. J. Gen. Virol. 2008, 89(October (Pt 10)):2622-2629.
213. Jiang X., Jayaram H., Kumar M., Ludtke S.J., Estes M.K., Prasad B.V. Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J. Virol. 2006, 80(November (21)):10829-10835.
214. Joensuu J., Koskenniemi E., Pang X.L., Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997, 350(October (9086)):1205-1209.
215. Johansson E., Istrate C., Charpilienne A., Cohen J., Hinkula J., Poncet D., Svensson L., Johansen K. Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles. Vaccine 2008, 26(February (6)):778-785.
216. Joosten V., Christien Lokman C., van den Hondel C., Punt P.J. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microbial Cell Fact. 2003, 2:1-5.
217. Kalica A.R., James A.D., Kapikian A.Z. Hemagglutination by simian rotavirus. J. Clin. Microbiol. 1978, 7(3):314-315.
218. Kam J., Demmert A.C., Tanner J.R., McDonald S.M., Kelly D.F. Sturctural dynamics of viral nanomachines. Technology 2014, 2(1):1-5.
219. ®) in a neonatal gnotobiotic pig model. Vaccine 2014, 32(February (7)):816-824.
220. Kang G. New-generation treatment? Targeted antiviral therapy for rotavirus. Gastroenterology 2013, 145(October (4)):711-714.
221. Kang G., Desai R., Arora R., Chitamabar S., Naik T.N., Krishnan T., Deshpande J., Gupte M.D., Venkatasubramaniam S., Gentsch J.R., Parashar U.D., Indian Rotavirus Strain Surveillance Network, Mathew A., Anita S.r., Ramani S., Sowmynarayanan T.V., Moses P.D., Agarwal I., Simon A., Bose A., Arora R., Chhabra P., Fadnis P., Bhatt J., Shetty S.J., Saxena V.K., Mathur M., Jadhav A., Roy S., Mukherjee A., Singh N.B. Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005-2009. Vaccine 2013, 31(June (27)):2879-2883.
222. Kapahnke R., Rappold W., Desselberger U., Riesner D. The stiffness of dsRNA: hydrodynamic studies on fluorescence-labelled RNA segments of bovine rotavirus. Nucleic Acids Res. 1986, 14(April (8)):3215-3228.
223. Kapikian A.Z., Hoshino Y., Chanock R.M., Perez-Schael I. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. Arch. Virol. Suppl. 1996, 12:163-175.
224. Kapusinszky B., Minor P., Delwart E. Nearly constant shedding of diverse enteric viruses by two healthy infants. J. Clin. Microbiol. 2012, 50(November (11)):3427-3434.
225. Kelkar S.D., Zade J.K. Group B rotaviruses similar to strain CAL-1, have been circulating in Western India since 1993. Epidemiol. Infect. 2004, 132(August (4)):745-749.
226. Keswick B.H., Pickering L.K., DuPont H.L., Woodward W.E. Survival and detection of rotaviruses on environmental surfaces in day care centers. Appl. Environ. Microbiol. 1983, 46(October (4)):813-816.
227. Kim I.S., Trask S.D., Babyonyshev M., Dormitzer P.R., Harrison S.C. Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry. J. Virol. 2010, 84(June (12)):6200-6207.
228. Kindler E., Trojnar E., Heckel G., Otto P.H., Johne R. Analysis of rotavirus species diversity and evolution including the newly determined full-length genome sequences of rotavirus F and G. Infect. Genet. Evol. 2013, 14(March):58-67.
229. Kobayashi T., Antar A.A., Boehme K.W., Danthi P., Eby E.A., Guglielmi K.M., Holm G.H., Johnson E.M., Maginnis M.S., Naik S., Skelton W.B., Wetzel J.D., Wilson G.J., Chappell J.D., Dermody T.S. A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 2007, 1(April (2)):147-157.
230. Kojima K., Taniguchi K., Kawagishi-Kobayashi M., Matsuno S., Urasawa S. Rearrangement generated in double genes, NSP1 and NSP3, of viable progenies from a human rotavirus strain. Virus Res. 2000, 67(April (2)):163-171.
231. Kojima K., Taniguchi K., Urasawa T., Urasawa S. Sequence analysis of normal and rearranged NSP5 genes from human rotavirus strains isolated in nature: implications for the occurrence of the rearrangement at the step of plus strand synthesis. Virology 1996, 224(October (2)):446-452.
232. Komoto S., Sasaki J., Taniguchi K. Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(March (12)):4646-4651.
233. Komoto S., Wakuda M., Ide T., Niimi G., Maeno Y., Higo-Moriguchi K., Taniguchi K. Modification of the trypsin cleavage site of rotavirus VP4 to a furin-sensitive form does not enhance replication efficiency. J. Gen. Virol. 2011, 92(December (Pt 12)):2914-2921.
234. Koo H.L., Neill F.H., Estes M.K., Munoz F.M., Cameron A., Dupont H.L., Atmar R.L. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J. Pediatric Infect. Dis. Soc. 2013, 2(March (1)):57-60.
235. Kordasti S., Sjövall H., Lundgren O., Svensson L. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut 2004, 53(July (7)):952-957.
236. La Frazia S., Ciucci A., Arnoldi F., Coira M., Gianferretti P., Angelini M., Belardo G., Burrone O.R., Rossignol J.F., Santoro M.G. Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation. J. Virol. 2013, 87(October (20)):11096-11106.
237. Lahon A., Maniya N.H., Tambe G.U., Chinchole P.R., Purwar S., Jacob G., Chitambar S.D. Group B rotavirus infection in patients with acute gastroenteritis from India: 1994-1995 and 2004-2010. Epidemiol. Infect. 2013, 141(May (5)):969-975.
238. Lappalainen S., Tamminen K., Vesikari T., Blazevic V. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum. Vaccin. Immunother. 2013, 9(September (9)):1991-2001.
239. Lawton J.A., Estes M.K., Prasad B.V. Three-dimensional visualization of mRNA release from actively transcribing rotavirus particles. Nat. Struct. Biol. 1997, 4(February (2)):118-121.
240. Le Pendu J., Nystroem K., Ruvoen-Clouet N. Host-pathogen co-evolution and glycan interactions. Curr. Opin. Virol. 2014, 7C(Jul (4)):88-94.
241. Leshem E., Moritz R.E., Curns A.T., Zhou F., Tate J.E., Lopman B.A., Parashar U.D. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007-2011). Pediatrics 2014, (June). pii:peds.2013-3849 (Epub ahead of print).
242. Li W., Manktelow E., von Kirchbach J.C., Gog J.R., Desselberger U., Lever A.M. Genomic analysis of codon, sequence and structural conservation with selective biochemical-structure mapping reveals highly conserved and dynamic structures in rotavirus RNAs with potential cis-acting functions. Nucleic Acids Res. 2010, 38(November (21)):7718-7735.
243. Libonati M.H., Dennis A.F., Ramani S., McDonald S.M., Akopov A., Kirkness E.F., Kang G., Patton J.T. Absence of genetic differences among G10P[11] rotaviruses associated with asymptomatic and symptomatic neonatal infections in Vellore, India. J. Virol. 2014, (June). pii:JVI.01417-14 (Epub ahead of print).
244. Liu F., Li G., Wen K., Wu S., Zhang Y., Bui T., Yang X., Kocher J., Sun J., Jortner B., Yuan L. Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs. J. Pediatr. Gastroenterol. Nutr. 2013, 57(December (6)):750-758.
245. Liu J., Kibiki G., Maro V., Maro A., Kumburu H., Swai N., Taniuchi M., Gratz J., Toney D., Kang G., Houpt E. Multiplex reverse transcription PCR Luminex assay for detection and quantitation of viral agents of gastroenteritis. J. Clin. Virol. 2011, 50(April (4)):308-313.
246. Liu L., Johnson H.L., Cousens S., Perin J., Scott S., Lawn J.E., Rudan I., Campbell H., Cibulskis R., Li M., Mathers C., Black R.E. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379(June (9832)):2151-2161. Child Health Epidemiology Reference Group of WHO and UNICEF.
247. López S., Arias C.F. Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol. 2004, 12(June (6)):271-278.
248. López T., Silva-Ayala D., López S., Arias C.F. Replication of the rotavirus genome requires an active ubiquitin-proteasome system. J. Virol. 2011, 85(November (22)):11964-11971.
249. Lopman B.A., Pitzer V.E., Sarkar R., Gladstone B., Patel M., Glasser J., Gambhir M., Atchison C., Grenfell B.T., Edmunds W.J., Kang G., Parashar U.D. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS ONE 2012, 7(8):e41720.
250. Lu X., McDonald S.M., Tortorici M.A., Tao Y.J., Vasquez-Del Carpio R., Nibert M.L., Patton J.T., Harrison S.C. Mechanism for coordinated RNA packaging and genome replication by rotavirus polymerase VP1. Structure 2008, 16(November (11)):1678-1688.
251. Luchs A., Timenetsky M.doC. G8P[6] rotaviruses isolated from Amerindian children in Mato Grosso do Sul, Brazil, during 2009: close relationship of the G and P genes with those of bovine and bat strains. J. Gen. Virol. 2014, 95(March (Pt 3)):627-641.
252. Ludert J.E., Michelangeli F., Gil F., Liprandi F., Esparza J. Penetration and uncoating of rotaviruses in cultured cells. Intervirology 1987, 27(2):95-101.
253. Lundgren O., Peregrin A.T., Persson K., Kordasti S., Uhnoo I., Svensson L. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000, 287(January (5452)):491-495.
254. Mackow E.R., Barnett J.W., Chan H., Greenberg H.B. The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. J. Virol. 1989, 63(April (4)):1661-1668.
255. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., Ngwira B., Victor J.C., Gillard P.H., Cheuvart B.B., Han H.H., Neuzil K.M. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 2010, 362(January (4)):289-298.
256. Maes P., Matthijnssens J., Rahman M., Van Ranst M. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol. 2009, 9(November):238.
257. Malek M.A., Curns A.T., Holman R.C., Fischer T.K., Bresee J.S., Glass R.I., Steiner C.A., Parashar U.D. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006, 117(June (6)):1887-1892.
258. Malherbe H., Harwin R. The cytopathic effects of vervet monkey viruses. S. Afr. Med. J. 1963, 37(April):407-411.
259. Martella V., Bányai K., Matthijnssens J., Buonavoglia C., Ciarlet M. Zoonotic aspects of rotaviruses. Vet. Microbiol. 2010, 140(January (3-4)):246-255.
260. Marthaler D., Rossow K., Culhane M., Collins J., Goyal S., Ciarlet M., Matthijnssens J. Identification, phylogenetic analysis and classification of porcine group C rotavirus VP7 sequences from the United States and Canada. Virology 2013, 446(November (1-2)):189-198.
261. Marthaler D., Rossow K., Culhane M., Goyal S., Collins J., Matthijnssens J., Nelson M., Ciarlet M. Widespread rotavirus H in commercially raised pigs, United States. Emerg. Infect. Dis. 2014, 20(7):1203-1206.
262. Marthaler D., Rossow K., Gramer M., Collins J., Goyal S., Tsunemitsu H., Kuga K., Suzuki T., Ciarlet M., Matthijnssens J. Detection of substantial porcine group B rotavirus genetic diversity in the United States, resulting in a modified classification proposal for G genotypes. Virology 2012, 433(November (1)):85-96.
263. Martin D., Duarte M., Lepault J., Poncet D. Sequestration of free tubulin molecules by the viral protein NSP2 induces microtubule depolymerization during rotavirus infection. J. Virol. 2010, 84(March (5)):2522-2532.
264. Martínez-Laso J., Román A., Rodriguez M., Cervera I., Head J., Rodríguez-Avial I., Picazo J.J. Diversity of the G3 genes of human rotaviruses in isolates from Spain from 2004 to 2006: cross-species transmission and inter-genotype recombination generated alleles. J. Gen. Virol. 2009, 90(April (Pt 4)):935-943.
265. Mathieu M., Petitpas I., Navaza J., Lepault J., Kohli E., Pothier P., Prasad B.V., Cohen J., Rey F.A. Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion. EMBO J. 2001, 20(April (7)):1485-1497.
266. Matson D.O. RotaShield: the ill-fated rhesus-human reassortant rotavirus vaccine. Pediatr. Ann. 2006, 35(January (1)):44-50.
267. Matsui S.M., Offit P.A., Vo P.T., Mackow E.R., Benfield D.A., Shaw R.D., Padilla-Noriega L., Greenberg H.B. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J. Clin. Microbiol. 1989, 27(4):780-782.
268. Matsui S.M., Mackow E.R., Greenberg H.B. Molecular determinant of rotavirus neutralization and protection. Adv. Virus Res. 1989, 36:181-214.
269. Matsuo E., Roy P. Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation. J. Virol. 2009, 83(September (17)):8842-8848.
270. Matthijnssens J., Ciarlet M., Heiman E., Arijs I., Delbeke T., McDonald S.M., Palombo E.A., Iturriza-Gómara M., Maes P., Patton J.T., Rahman M., Van Ranst M. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J. Virol. 2008, 82(April (7)):3204-3219.
271. Matthijnssens J., Ciarlet M., McDonald S.M., Attoui H., Bányai K., Brister J.R., Buesa J., Esona M.D., Estes M.K., Gentsch J.R., Iturriza-Gómara M., Johne R., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Parreño V., Rahman M., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Patton J.T., Desselberger U., Van Ranst M. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol 2011, 156(August (8)):1397-1413.
272. Matthijnssens J., Ciarlet M., Rahman M., Attoui H., Bányai K., Estes M.K., Gentsch J.R., Iturriza-Gómara M., Kirkwood C.D., Martella V., Mertens P.P., Nakagomi O., Patton J.T., Ruggeri F.M., Saif L.J., Santos N., Steyer A., Taniguchi K., Desselberger U., Van Ranst M. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch. Virol 2008, 153(8):1621-1629.
273. Matthijnssens J., De Grazia S., Piessens J., Heylen E., Zeller M., Giammanco G.M., Bányai K., Buonavoglia C., Ciarlet M., Martella V., Van Ranst M. Multiple reassortment and interspecies transmission events contribute to the diversity of feline, canine and feline/canine-like human group A rotavirus strains. Infect. Genet. Evol. 2011, 11(August (6)):1396-1406.
274. Matthijnssens J., Otto P.H., Ciarlet M., Desselberger U., Van Ranst M., Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch. Virol 2012, 157(June (6)):1177-1182.
275. Matthijnssens J., Van Ranst M. Genotype constellation and evolution of group A rotaviruses infecting humans. Curr. Opin. Virol. 2012, 2(August (4)):426-433.
276. Matthijnssens J., Zeller M., Heylen E., De Coster S., Vercauteren J., Braeckman T., Van Herck K., Meyer N., Pirçon J.Y., Soriano-Gabarro M., Azou M., Capiau H., De Koster J., Maernoudt A.S., Raes M., Verdonck L., Verghote M., Vergison A., Van Damme P., Van Ranst M. The RotaBel study group, Higher proportion of G2P[4] rotaviruses in vaccinated hospitalised cases compared to unvaccinated hospitalised cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clin. Microbiol. Infect. 2014, (Mar). (Epub ahead of print). 10.1111/1469-0691.12612.
277. McClain B., Settembre E., Temple B.R., Bellamy A.R., Harrison S.C. X-ray crystal structure of the rotavirus inner capsid particle at 3.8Å resolution. J. Mol. Biol. 2010, 397(March (2)):587-599.
278. McClenahan S.D., Krause P.R., Uhlenhaut C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29(June (29-30)):4745-4753.
279. McIntyre M., Rosenbaum V., Rappold W., Desselberger M., Wood D., Desselberger U. Biophysical characterization of rotavirus particles containing rearranged genomes. J. Gen. Virol. 1987, 68(November (Pt 11)):2961-2966.
280. McNulty M.S., Curran W.L., McFerran J.B. The morphogenesis of a cytopathic bovine rotavirus in Madin-Darby bovine kidney cells. J. Gen. Virol. 1976, 33(December (3)):503-508.
281. Mebus C.A., Underdahl N.R., Rhodes M.B., Twiehaus M.J. Further studies on neonatal calf diarrhea virus. Proc. Annu. Meet. U. S. Anim. Health Assoc. 1969, 73:97-99.
282. Minot S., Bryson A., Chehoud C., Wu G.D., Lewis J.D., Bushman F.D. Rapid evolution of the human gut virome. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(July (30)):12450-12455.
283. Minot S., Grunberg S., Wu G.D., Lewis J.D., Bushman F.D. Hypervariable loci in the human gut virome. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(March (10)):3962-3966.
284. Mohanty S.K., Donnelly B., Bondoc A., Jafri M., Walther A., Coots A., McNeal M., Witte D., Tiao G.M. Rotavirus replication in the cholangiocyte mediates the temporal dependence of murine biliary atresia. PLoS ONE 2013, 8(July (7)):e69069.
285. Molinari B.L., Lorenzetti E., Otonel R.A., Alfieri A.F., Alfieri A.A. Species h rotavirus detected in piglets with diarrhea, Brazil, 2012. Emerg. Infect. Dis. 2014, 20(June (6)):1019-1022.
286. Montero H., Arias C.F., Lopez S. Rotavirus nonstructural protein NSP3 is not required for viral protein synthesis. J. Virol. 2006, 80(September (18)):9031-9038.
287. Mrukowicz J.Z., Wetzel J.D., Goral M.I., Fogo A.B., Wright P.F., Dermody T.S. Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J. Virol. 1998, 72(April (4)):3088-3097.
288. Mullick S., Mukherjee A., Ghosh S., Pazhani G.P., Sur D., Manna B., Nataro J.P., Levine M.M., Ramamurthy T., Chawla-Sarkar M. Genomic analysis of human rotavirus strains G6P[14] and G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events. Infect. Genet. Evol. 2013, 14(March):15-21.
289. Murphy B.R., Morens D.M., Simonsen L., Chanock R.M., La Montagne J.R., Kapikian A.Z. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J. Infect. Dis. 2003, 187(April (8)):1301-1308.
290. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., Zanardi L.R., Setia S., Fair E., LeBaron C.W., Wharton M., Livengood J.R. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 2001, 344(February (8)):564-572. Rotavirus Intussusception Investigation Team.
291. Murphy T.V., Smith P.J., Gargiullo P.M., Schwartz B. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J. Infect. Dis. 2003, 187(April (8)):1309-1313.
292. Mwenda J.M., Ntoto K.M., Abebe A., Enweronu-Laryea C., Amina I., Mchomvu J., Kisakye A., Mpabalwani E.M., Pazvakavambwa I., Armah G.E., Seheri L.M., Kiulia N.M., Page N., Widdowson M.A., Steele A.D. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J. Infect. Dis. 2010, 202(September (Suppl.)):S5-S11.
293. Nandi S., Chanda S., Bagchi P., Nayak M.K., Bhowmick R., Chawla-Sarkar M. MAVS protein is attenuated by rotavirus nonstructural protein 1. PLoS ONE 2014, 9(March (3)):e92126.
294. Navarro A., Trask S.D., Patton J.T. Generation of genetically stable recombinant rotaviruses containing novel genome rearrangements and heterologous sequences by reverse genetics. J. Virol. 2013, 87(June (11)):6211-6220.
295. Nejmeddine M., Trugnan G., Sapin C., Kohli E., Svensson L., Lopez S., Cohen J. Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells. J. Virol. 2000, 74(April (7)):3313-3320.
296. Newton K., Meyer J.C., Bellamy A.R., Taylor J.A. Rotavirus nonstructural glycoprotein NSP4 alters plasma membrane permeability in mammalian cells. J. Virol. 1997, 71(December (12)):9458-9465.
297. Nilsson M., Svenungsson B., Hedlund K.O., Uhnoo I., Lagergren A., Akre T., Svensson L. Incidence and genetic diversity of group C rotavirus among adults. J. Infect. Dis. 2000, 182(September (3)):678-684.
298. Offit P.A. Rotaviruses: immunological determinants of protection against infection and disease. Adv. Virus Res. 1994, 44:161-202.
299. Offit P.A., Clark H.F., Blavat G., Greenberg H.B. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J. Virol. 1986, 60(November (2)):491-496.
300. Offit P.A., Shaw R.D., Greenberg H.B. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J. Virol. 1986, 58(May (2)):700-703.
301. O'Neal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 1997, 71(November (11)):8707-8717.
302. O'Neal C.M., Harriman G.R., Conner M.E. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J. Virol. 2000, 74(May (9)):4102-4109.
303. O'Neill H.G., Mlera L., Wentzel J., van Dijk A.A. Rotavirus transcripts activate protein kinase R, are sensed by RIG-I and induce IFN-gamma, IFN lambda-1 and CXCL10 in HEK293H cells. 5th European Rotavirus Biology Meeting 2013, 19. Abstract book O-03.
304. Osborne M.P., Haddon S.J., Worton K.J., Spencer A.J., Starkey W.G., Thornber D., Stephen J. Rotavirus-induced changes in the microcirculation of intestinal villi of neonatal mice in relation to the induction and persistence of diarrhea. J. Pediatr. Gastroenterol. Nutr. 1991, 12(January (1)):111-120.
305. Otto P.H., Ahmed M.U., Hotzel H., Machnowska P., Reetz J., Roth B., Trojnar E., Johne R. Detection of avian rotaviruses of groups A, D, F and G in diseased chickens and turkeys from Europe and Bangladesh. Vet. Microbiol. 2012, 156(April (1-2)):8-15.
306. Papp H., Borzák R., Farkas S., Kisfali P., Lengyel G., Molnár P., Melegh B., Matthijnssens J., Jakab F., Martella V., Bányai K. Zoonotic transmission of reassortant porcine G4P[6] rotaviruses in Hungarian pediatric patients identified sporadically over a 15 year period. Infect. Genet. Evol. 2013, 19(October):71-80.
307. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., Birmingham M., Glass R.I. Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis. 2009, 200(November (Suppl. 1)):S9-S15.
308. Parashar U.D., Gibson C.J., Bresee J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis. 2006, 12(February (2)):304-306.
309. Parashar U.D., Orenstein W.A. Editorial commentary: intussusception and rotavirus vaccination--balancing risk against benefit. Clin. Infect. Dis. 2013, 57(November (10)):1435-1437.
310. Parra G.I., Bok K., Martínez M., Gomez J.A. Evidence of rotavirus intragenic recombination between two sublineages of the same genotype. J. Gen. Virol. 2004, 85(June (Pt 6)):1713-1716.
311. Parra M., Herrera D., Calvo-Calle J.M., Stern L.J., Parra-López C.A., Butcher E., Franco M., Angel J. Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9. Virology 2014, 452-453(March):191-201.
312. Pastor A.R., Rodríguez-Limas W.A., Contreras M.A., Esquivel E., Esquivel-Guadarrama F., Ramírez O.T., Palomares L.A. The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice. Vaccine 2014, 32(May (24)):2874-2877.
313. Patel M., Glass R.I., Jiang B., Santosham M., Lopman B., Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J. Infect. Dis. 2013, 208(July (2)):284-294.
314. Patel M.M., López-Collada V.R., Bulhões M.M., De Oliveira L.H., Bautista Márquez A., Flannery B., Esparza-Aguilar M., Montenegro Renoiner E.I., Luna-Cruz M.E., Sato H.K., Hernández-Hernández Ldel C., Toledo-Cortina G., Cerón-Rodríguez M., Osnaya-Romero N., Martínez-Alcazar M., Aguinaga-Villasenor R.G., Plascencia-Hernández A., Fojaco-González F., Hernández-Peredo Rezk G., Gutierrez-Ramírez S.F., Dorame-Castillo R., Tinajero-Pizano R., Mercado-Villegas B., Barbosa M.R., Maluf E.M., Ferreira L.B., de Carvalho F.M., dos Santos A.R., Cesar E.D., de Oliveira M.E., Silva C.L., de Los Angeles Cortes M., Ruiz Matus C., Tate J., Gargiullo P., Parashar U.D. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N. Engl. J. Med. 2011, 364(June (24)):2283-2292.
315. Patel M.M., Parashar U.D. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J. Infect. Dis. 2009, 200(November (Suppl. 1)):S291-S299.
316. Patel N.C., Hertel P.M., Estes M.K., de la Morena M., Petru A.M., Noroski L.M., Revell P.A., Hanson I.C., Paul M.E., Rosenblatt H.M., Abramson S.L. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N. Engl. J. Med. 2010, 362(January (4)):314-319.
317. Payne D.C., Boom J.A., Staat M.A., Edwards K.M., Szilagyi P.G., Klein E.J., Selvarangan R., Azimi P.H., Harrison C., Moffatt M., Johnston S.H., Sahni L.C., Baker C.J., Rench M.A., Donauer S., McNeal M., Chappell J., Weinberg G.A., Tasslimi A., Tate J.E., Wikswo M., Curns A.T., Sulemana I., Mijatovic-Rustempasic S., Esona M.D., Bowen M.D., Gentsch J.R., Parashar U.D. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin. Infect. Dis. 2013, 57(July (1)):13-20.
318. Payne D.C., Vinjé J., Szilagyi P.G., Edwards K.M., Staat M.A., Weinberg G.A., Hall C.B., Chappell J., Bernstein D.I., Curns A.T., Wikswo M., Shirley S.H., Hall A.J., Lopman B., Parashar U.D. Norovirus and medically attended gastroenteritis in U.S. children. N. Engl. J. Med. 2013, 368(March (12)):1121-1130.
319. Pedley S., Hundley F., Chrystie I., McCrae M.A., Desselberger U. The genomes of rotaviruses isolated from chronically infected immunodeficient children. J. Gen. Virol. 1984, 65(July (Pt 7)):1141-1150.
320. Peláez-Carvajal D., Cotes-Cantillo K., Paternina-Caicedo A., Gentsch J., de la Hoz-Restrepo F., Patel M. Characterization of rotavirus genotypes before and after the introduction of a monovalent rotavirus vaccine in Colombia. J. Med. Virol. 2014, 86(June (6)):1083-1086.
321. Pérez-Schael I., Guntiñas M.J., Pérez M., Pagone V., Rojas A.M., González R., Cunto W., Hoshino Y., Kapikian A.Z. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med. 1997, 337(October (17)):1181-1187.
322. Pérez-Vargas J., Romero P., López S., Arias C.F. The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity. J. Virol. 2006, 80(April (7)):3322-3331.
323. Periz J., Celma C., Jing B., Pinkney J.N., Roy P., Kapanidis A.N. Rotavirus mRNAS are released by transcript-specific channels in the double-layered viral capsid. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(July (29)):12042-12047.
324. Peter G., Myers M.G. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 2002, 110(December (6)):e67. National Vaccine Advisory Committee; National Vaccine Program Office.
325. Phan T.G., Okitsu S., Maneekarn N., Ushijima H. Evidence of intragenic recombination in G1 rotavirus VP7 genes. J. Virol. 2007, 81(September (18)):10188-10194.
326. Phan T.G., Vo N.P., Bonkoungou I.J., Kapoor A., Barro N., O'Ryan M., Kapusinszky B., Wang C., Delwart E. Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus. J. Virol. 2012, 86(October (20)):11024-11030.
327. Pickering L.K., Bartlett A.V., 3rd, Reves R.R., Morrow A. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J. Pediatr. 1988, 112(March (3)):361-365.
328. Piron M., Delaunay T., Grosclaude J., Poncet D. Identification of the RNA-binding, dimerization, and eIF4GI-binding domains of rotavirus nonstructural protein NSP3. J. Virol. 1999, 73(July (7)):5411-5421.
329. Piron M., Vende P., Cohen J., Poncet D. Rotavirus RNA-binding protein NSP3 interacts with eIF4GI and evicts the poly(A) binding protein from eIF4F. EMBO J. 1998, 17(October (19)):5811-5821.
330. Pizarro D., Posada G., Sandi L., Moran J.R. Rice-based oral electrolyte solutions for the management of infantile diarrhea. N. Engl. J. Med. 1991, 324(February (8)):517-521. Erratum in: N. Engl. J. Med. 1992, 326 (February (7)), 488-489.
331. Prasad B.V., Rothnagel R., Zeng C.Q., Jakana J., Lawton J.A., Chiu W., Estes M.K. Visualization of ordered genomic RNA and localization of transcriptional complexes in rotavirus. Nature 1996, 382(August (6590)):471-473.
332. Qin L., Ren L., Zhou Z., Lei X., Chen L., Xue Q., Liu X., Wang J., Hung T. Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I. Virol. J. 2011, 8(December):526.
333. Quintanar-Solares M., Yen C., Richardson V., Esparza-Aguilar M., Parashar U.D., Patel M.M. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatr. Infect. Dis. J. 2011, 30(January (1 Suppl.)):S11-S15.
334. Ramani S., Cortes-Penfield N.W., Hu L., Crawford S.E., Czako R., Smith D.F., Kang G., Ramig R.F., Le Pendu J., Prasad B.V., Estes M.K. The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J. Virol. 2013, 87(July (13)):7255-7264.
335. Ramani S., Paul A., Saravanabavan A., Menon V.K., Arumugam R., Sowmyanarayanan T.V., Samuel P., Kang G. Rotavirus antigenemia in Indian children with rotavirus gastroenteritis and asymptomatic infections. Clin. Infect. Dis. 2010, 51(December (11)):1284-1289.
336. Ramig R.F. Systemic rotavirus infection. Expert Rev. Anti Infect. Ther. 2007, 5(August (4)):591-612.
337. Ramig R.F. Pathogenesis of intestinal and systemic rotavirus infection. J. Virol. 2004, 78(October (19)):10213-10220.
338. Ray P.G., Kelkar S.D., Walimbe A.M., Biniwale V., Mehendale S. Rotavirus immunoglobulin levels among Indian mothers of two socio-economic groups and occurrence of rotavirus infections among their infants up to six months. J. Med. Virol. 2007, 79(March (3)):341-349.
339. Rha B., Tate J.E., Payne D.C., Cortese M.M., Lopman B.A., Curns A.T., Parashar U.D. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev. Vaccines 2014, 13(March (3)):365-376.
340. Richards J.E., Desselberger U., Lever A.M. Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells. PLoS ONE 2013, 8(September (9)):e74328.
341. Richardson S., Grimwood K., Gorrell R., Palombo E., Barnes G., Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998, 351(June (9119)):1844-1848.
342. Richardson V., Hernandez-Pichardo J., Quintanar-Solares M., Esparza-Aguilar M., Johnson B., Gomez-Altamirano C.M., Parashar U., Patel M. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med. 2010, 362(January (4)):299-305.
343. Riepenhoff-Talty M., Dharakul T., Kowalski E., Michalak S., Ogra P.L. Persistent rotavirus infection in mice with severe combined immunodeficiency. J. Virol. 1987, 61(October (10)):3345-3348.
344. Rodríguez J.M., Chichón F.J., Martín-Forero E., González-Camacho F., Carrascosa J.L., Castón J.R., Luque D. New insights into rotavirus entry machinery: stabilization of rotavirus spike conformation is independent of trypsin cleavage. PLoS Pathog. 2014, 10(May (5)):e1004157.
345. Rodríguez M., Wood C., Sanchez-López R., Castro-Acosta R.M., Ramírez O.T., Palomares L.A. Understanding internalization of rotavirus VP6 nanotubes by cells: towards a recombinant vaccine. Arch. Virol. 2013, (November). (Epub ahead of print).
346. Rodríguez-Limas W.A., Pastor A.R., Esquivel-Soto E., Esquivel-Guadarrama F., Ramírez O.T., Palomares L.A. Immunogenicity and protective efficacy of yeast extracts containing rotavirus-like particles: a potential veterinary vaccine. Vaccine 2014, 32(May (24)):2794-2798.
347. Rojas O.L., González A.M., González R., Pérez-Schael I., Greenberg H.B., Franco M.A., Angel J. Human rotavirus specific T cells: quantification by ELISPOT and expression of homing receptors on CD4+ T cells. Virology 2003, 314(September (2)):671-679.
348. Rojas O.L., Narváez C.F., Greenberg H.B., Angel J., Franco M.A. Characterization of rotavirus specific B cells and their relation with serological memory. Virology 2008, 380(October (2)):234-242.
349. Rossignol J.F., Abu-Zekry M., Hussein A., Santoro M.G. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet 2006, 368(July (9530)):124-129.
350. Rotavirus Classification Working Group, 6th meeting, Valencia, October 2013.
351. Rubio R.M., Mora S.I., Romero P., Arias C.F., López S. Rotavirus prevents the expression of host responses by blocking the nucleocytoplasmic transport of polyadenylated mRNAs. J. Virol. 2013, 87(June (11)):6336-6345.
352. Ruiz-Palacios G.M., Pérez-Schael I., Velázquez F.R., Abate H., Breuer T., Clemens S.C., Cheuvart B., Espinoza F., Gillard P., Innis B.L., Cervantes Y., Linhares A.C., López P., Macías-Parra M., Ortega-Barría E., Richardson V., Rivera-Medina D.M., Rivera L., Salinas B., Pavía-Ruz N., Salmerón J., Rüttimann R., Tinoco J.C., Rubio P., Nuñez E., Guerrero M.L., Yarzábal J.P., Damaso S., Tornieporth N., Sáez-Llorens X., Vergara R.F., Vesikari T., Bouckenooghe A., Clemens R., De Vos B., O'Ryan M. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 2006, 354(January (1)):11-22. Human Rotavirus Vaccine Study Group.
353. Ryan E.T. The intestinal pathobiome: its reality and consequences among infants and young children in resource-limited settings. J. Infect. Dis. 2013, 208(December (11)):1732-1733.
354. Sachsenroder J., Twardziok S., Hammerl J.A., Janczyk P., Wrede P., Hertwig S., Johne R. Simultaneous identification of DNA and RNA viruses present in pig faeces using process-controlled deep sequencing. PLoS ONE 2012, 7:e34631.
355. SAGE Meeting of the Immunization Strategic Advisory Group of Experts, April 2009 - conclusions and recommendations. Wkly. Epidem. Rec. 2009, 84:220-235.
356. Salazar-Lindo E., Santisteban-Ponce J., Chea-Woo E., Gutierrez M. Racecadotril in the treatment of acute watery diarrhea in children. N. Engl. J. Med. 2000, 343(August (7)):463-467.
357. Sánchez-San Martín C., López T., Arias C.F., López S. Characterization of rotavirus cell entry. J. Virol. 2004, 78(March (5)):2310-2318.
358. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 2005, 15(January-February (1)):29-56.
359. Santosham M., Moulton L.H., Reid R., Croll J., Weatherholt R., Ward R., Forro J., Zito E., Mack M., Brenneman G., Davidson B.L. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J. Pediatr. 1997, 131(October (4)):632-638.
360. Sapparapu G., Sims A.L., Aiyegbo M.S., Shaikh F.Y., Harth E.M., Crowe J.E. Intracellular neutralization of a virus using a cell-penetrating molecular transporter. Nanomedicine (Lond.) 2013, (November). (Epub ahead of print).
361. Sarker S.A., Jäkel M., Sultana S., Alam N.H., Bardhan P.K., Chisti M.J., Salam M.A., Theis W., Hammarström L., Frenken L.G. Anti-rotavirus protein reduces stool output in infants with diarrhea: a randomized placebo-controlled trial. Gastroenterology 2013, 145(October (4)). 740-748.e8.
362. Saulsbury F.T., Winkelstein J.A., Yolken R.H. Chronic rotavirus infection in immunodeficiency. J. Pediatr. 1980, 97(July (1)):61-65.
363. Schwartz-Cornil I., Benureau Y., Greenberg H., Hendrickson B.A., Cohen J. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J. Virol. 2002, 76(August (16)):8110-8117.
364. Sen A., Pruijssers A.J., Dermody T.S., García-Sastre A., Greenberg H.B. The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. J. Virol. 2011, 85(April (8)):3717-3732.
365. Sen A., Rothenberg M.E., Mukherjee G., Feng N., Kalisky T., Nair N., Johnstone I.M., Clarke M.F., Greenberg H.B. Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(December (50)):20667-20672.
366. Sen A., Rott L., Phan N., Mukherjee G., Greenberg H.B. Rotavirus NSP1 protein inhibits interferon-mediated STAT1 activation. J. Virol. 2014, 88(January (1)):41-53.
367. Senturia Y.D., Peckham C.S., Cordery M., Chrystie I.A., Banatvala J.E., André F.E. Live attenuated oral rotavirus vaccine. Lancet 1987, 2(November (8567)):1091-1092.
368. Seo N.S., Zeng C.Q., Hyser J.M., Utama B., Crawford S.E., Kim K.J., Höök M., Estes M.K. Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(July (26)):8811-8818.
369. Settembre E.C., Chen J.Z., Dormitzer P.R., Grigorieff N., Harrison S.C. Atomic model of an infectious rotavirus particle. EMBO J. 2011, 30(January (2)):408-416.
370. Silva-Ayala D., López T., Gutiérrez M., Perrimon N., López S., Arias C.F. Genome-wide RNAi screen reveals a role for the ESCRT complex in rotavirus cell entry. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(June (25)):10270-10275.
371. Silvestri L.S., Taraporewala Z.F., Patton J.T. Rotavirus replication: plus-sense templates for double-stranded RNA synthesis are made in viroplasms. J. Virol. 2004, 78(July (14)):7763-7774.
372. Silvestri L.S., Tortorici M.A., Vasquez-Del Carpio R., Patton J.T. Rotavirus glycoprotein NSP4 is a modulator of viral transcription in the infected cell. J. Virol. 2005, 79(December (24)):15165-15174.
373. Simmonds M.K., Armah G., Asmah R., Banerjee I., Damanka S., Esona M., Gentsch J.R., Gray J.J., Kirkwood C., Page N., Iturriza-Gómara M. New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J. Clin. Virol. 2008, 42(August (4)):368-373.
374. Simonsen L., Viboud C., Elixhauser A., Taylor R.J., Kapikian A.Z. More on RotaShield and intussusception: the role of age at the time of vaccination. J. Infect. Dis. 2005, 192(September (Suppl. 1)):S36-S43.
375. Soma J., Tsunemitsu H., Miyamoto T., Suzuki G., Sasaki T., Suzuki T. Whole-genome analysis of two bovine rotavirus C strains: Shintoku and Toyama. J. Gen. Virol. 2013, 94(January (Pt 1)):128-135.
376. Soriano-Gabarró M., Mrukowicz J., Vesikari T., Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr. Infect. Dis. J. 2006, 25(January (1 Suppl.)):S7-S11.
377. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., Hoskins E.E., Kalinichenko V.V., Wells S.I., Zorn A.M., Shroyer N.F., Wells J.M. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470(February (7332)):105-109.
378. Spencer E., Arias M.L. In vitro transcription catalyzed by heat-treated human rotavirus. J. Virol. 1981, 40(October (1)):1-10.
379. Stacy-Phipps S., Patton J.T. Synthesis of plus- and minus-strand RNA in rotavirus-infected cells. J. Virol. 1987, 61(November (11)):3479-3484.
380. Stephen A.C., Baumeister W. The state of the art. J. Struct. Biol. 2008, 163:201-207.
381. Steyer A., Poljsak-Prijatelj M., Barlic-Maganja D., Marin J. Human, porcine and bovine rotaviruses in Slovenia: evidence of interspecies transmission and genome reassortment. J. Gen. Virol. 2008, 89(July (Pt 7)):1690-1698.
382. Steyer A., Sagadin M., Kolenc M., Poljšak-Prijatelj M. Whole genome sequence analysis of bovine G6P[11] rotavirus strain found in a child with gastroenteritis. Infect. Genet. Evol. 2013, 13(January):89-95.
383. Tamminen K., Lappalainen S., Huhti L., Vesikari T., Blazevic V. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS ONE 2013, 8(July (7)):e70409.
384. Tan M., Jiang X. Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev. Mol. Med. 2014, 16(March):e5.
385. Tao Y., Farsetta D.L., Nibert M.L., Harrison S.C. RNA synthesis in a cage - structural studies of reovirus polymerase lambda3. Cell 2002, 111(November (5)):733-745.
386. Taraporewala Z., Chen D., Patton J.T. Multimers formed by the rotavirus nonstructural protein NSP2 bind to RNA and have nucleoside triphosphatase activity. J. Virol. 1999, 73(December (12)):9934-9943.
387. Taraporewala Z.F., Patton J.T. Identification and characterization of the helix-destabilizing activity of rotavirus nonstructural protein NSP2. J. Virol. 2001, 75(May (10)):4519-4527.
388. Taraporewala Z.F., Patton J.T. Nonstructural proteins involved in genome packaging and replication of rotaviruses and other members of the Reoviridae. Virus Res. 2004, 101(April (1)):57-66.
389. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. WHO-coordinated Global Rotavirus Surveillance Network, 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12(February (2)):136-141.
390. Tate J.E., Cortese M.M., Payne D.C., Curns A.T., Yen C., Esposito D.H., Cortes J.E., Lopman B.A., Patel M.M., Gentsch J.R., Parashar U.D. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr. Infect. Dis. J. 2011, 30(January (1 Suppl.)):S56-S60.
391. Tate J.E., Haynes A., Payne D.C., Cortese M.M., Lopman B.A., Patel M.M., Parashar U.D. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. Pediatr. Infect. Dis. J. 2013, 32(July (7)):741-744.
392. Tate J.E., Mutuc J.D., Panozzo C.A., Payne D.C., Cortese M.M., Cortes J.E., Yen C., Esposito D.H., Lopman B.A., Patel M.M., Parashar U.D. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr. Infect. Dis. J. 2011, 30(January (1 Suppl.)):S30-S34.
393. Taylor J.A., O'Brien J.A., Yeager M. The cytoplasmic tail of NSP4, the endoplasmic reticulum-localized non-structural glycoprotein of rotavirus, contains distinct virus binding and coiled coil domains. EMBO J. 1996, 15(September (17)):4469-4476.
394. Teran C.G., Teran-Escalera C.N., Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int. J. Infect. Dis. 2009, 13(July (4)):518-523.
395. Tian P., Ball J.M., Zeng C.Q., Estes M.K. The rotavirus nonstructural glycoprotein NSP4 possesses membrane destabilization activity. J. Virol. 1996, 70(October (10)):6973-6981.
396. Tian P., Hu Y., Schilling W.P., Lindsay D.A., Eiden J., Estes M.K. The nonstructural glycoprotein of rotavirus affects intracellular calcium levels. J. Virol. 1994, 68(January (1)):251-257.
397. Todd S., Page N.A., Duncan Steele A., Peenze I., Cunliffe N.A. Rotavirus strain types circulating in Africa: review of studies published during 1997-2006. J. Infect. Dis. 2010, 202(September (Suppl.)):S34-S42.
398. Tokuhara D., Álvarez B., Mejima M., Hiroiwa T., Takahashi Y., Kurokawa S., Kuroda M., Oyama M., Kozuka-Hata H., Nochi T., Sagara H., Aladin F., Marcotte H., Frenken L.G., Iturriza-Gómara M., Kiyono H., Hammarström L., Yuki Y. Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J. Clin. Invest. 2013, 123(September (9)):3829-3838.
399. Torres-Vega M.A., González R.A., Duarte M., Poncet D., López S., Arias C.F. The C-terminal domain of rotavirus NSP5 is essential for its multimerization, hyperphosphorylation and interaction with NSP6. J. Gen. Virol. 2000, 81(March (Pt 3)):821-830.
400. Tortorici M.A., Broering T.J., Nibert M.L., Patton J.T. Template recognition and formation of initiation complexes by the replicase of a segmented double-stranded RNA virus. J. Biol. Chem. 2003, 278(August (35)):32673-32682.
401. Tortorici M.A., Shapiro B.A., Patton J.T. A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments. RNA 2006, 12(January (1)):133-146.
402. Trask S.D., Dormitzer P.R. Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J. Virol. 2006, 80(November (22)):11293-11304.
403. Trask S.D., Kim I.S., Harrison S.C., Dormitzer P.R. A rotavirus spike protein conformational intermediate binds lipid bilayers. J. Virol. 2010, 84(February (4)):1764-1770.
404. Trask S.D., McDonald S.M., Patton J.T. Structural insights into the coupling of virion assembly and rotavirus replication. Nat Rev Microbiol 2012, 10(January (3)):165-177. Erratum in: Nat. Rev. Microbiol., 2014, 12 (January (1)), 70.
405. Trask S.D., Ogden K.M., Patton J.T. Interactions among capsid proteins orchestrate rotavirus particle functions. Curr. Opin. Virol. 2012, 2(August (4)):373-379.
406. Trask S.D., Taraporewala Z.F., Boehme K.W., Dermody T.S., Patton J.T. Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(October (43)):18652-18657.
407. Trask S.D., Wetzel J.D., Dermody T.S., Patton J.T. Mutations in the rotavirus spike protein VP4 reduce trypsin sensitivity but not viral spread. J. Gen. Virol. 2013, 94(June (Pt 6)):1296-1300.
408. Tregnaghi M.W., Abate H.J., Valencia A., Lopez P., Da Silveira T.R., Rivera L., Rivera Medina D.M., Saez-Llorens X., Gonzalez Ayala S.E., De León T., Van Doorn L.J., Pilar Rubio M.D., Suryakiran P.V., Casellas J.M., Ortega-Barria E., Smolenov I.V., Han H.H. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr. Infect. Dis. J. 2011, 30(June (6)):e103-e108. Rota-024 Study Group.
409. Trojnar E., Otto P., Johne R. The first complete genome sequence of a chicken group A rotavirus indicates independent evolution of mammalian and avian strains. Virology 2009, 386(April (2)):325-333.
410. Troupin C., Dehée A., Schnuriger A., Vende P., Poncet D., Garbarg-Chenon A. Rearranged genomic RNA segments offer a new approach to the reverse genetics of rotaviruses. J. Virol. 2010, 84(July (13)):6711-6719.
411. Uzri D., Greenberg H.B. Characterization of rotavirus RNAs that activate innate immune signaling through the RIG-I-like receptors. PLoS ONE 2013, 8(July (7)):e69825.
412. Vancott J.L., McNeal M.M., Choi A.H., Ward R.L. The role of interferons in rotavirus infections and protection. J. Interferon Cytokine Res. 2003, 23(March (3)):163-170.
413. Van Damme P., Giaquinto C., Huet F., Gothefors L., Maxwell M., Van der Wielen M. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J. Infect. Dis. 2007, 195(May (Suppl. 1)):S4-S16. REVEAL Study Group.
414. van der Vaart J.M., Pant N., Wolvers D., Bezemer S., Hermans P.W., Bellamy K., Sarker S.A., van der Logt C.P., Svensson L., Verrips C.T., Hammarstrom L., van Klinken B.J. Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine 2006, 24(May (19)):4130-4137.
415. Vascotto F., Campagna M., Visintin M., Cattaneo A., Burrone O.R. Effects of intrabodies specific for rotavirus NSP5 during the virus replicative cycle. J. Gen. Virol. 2004, 85(November (Pt 11)):3285-3290.
416. Vega C.G., Bok M., Vlasova A.N., Chattha K.S., Gómez-Sebastián S., Nuñez C., Alvarado C., Lasa R., Escribano J.M., Garaicoechea L.L., Fernandez F., Bok K., Wigdorovitz A., Saif L.J., Parreño V. Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea. PLoS Pathog. 2013, 9(5):e1003334.
417. Velázquez F.R., Matson D.O., Calva J.J., Guerrero L., Morrow A.L., Carter-Campbell S., Glass R.I., Estes M.K., Pickering L.K., Ruiz-Palacios G.M. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med. 1996, 335(October (14)):1022-1028.
418. Vende P., Gratia M., Duarte M.D., Charpilienne A., Saguy M., Poncet D. Identification of mutations in the genome of rotavirus SA11 temperature-sensitive mutants D, H, I and J by whole genome sequences analysis and assignment of tsI to gene 7 encoding NSP3. Virus Res. 2013, 176(September (1-2)):144-154.
419. Vende P., Piron M., Castagné N., Poncet D. Efficient translation of rotavirus mRNA requires simultaneous interaction of NSP3 with the eukaryotic translation initiation factor eIF4G and the mRNA 3' end. J. Virol. 2000, 74(August (15)):7064-7071.
420. ®, in Finnish infants up to 3 years of age: the Finnish Extension Study. Eur. J. Pediatr. 2010, 169(November (11)):1379-1386.
421. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., Meurice F., Han H.H., Damaso S., Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370(November (9601)):1757-1763.
422. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Thollot F., Garcia-Corbeira P., Damaso S., Han H.H., Bouckenooghe A. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine 2010, 28(July (32)):5272-5279.
423. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., Dallas M.J., Heyse J.F., Goveia M.G., Black S.B., Shinefield H.R., Christie C.D., Ylitalo S., Itzler R.F., Coia M.L., Onorato M.T., Adeyi B.A., Marshall G.S., Gothefors L., Campens D., Karvonen A., Watt J.P., O'Brien K.L., DiNubile M.J., Clark H.F., Boslego J.W., Offit P.A., Heaton P.M. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 2006, 354(January (1)):23-33. Rotavirus Efficacy and Safety Trial (REST) Study Team.
424. Victoria J.G., Wang C., Jones M.S., Jaing C., McLoughlin K., Gardner S., Delwart E.L. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 2010, 84(June (12)):6033-6040.
425. Virgin H.W. The virome in mammalian physiology and disease. Cell 2014, 157(March (1)):142-150.
426. Vlasova A.N., Chattha K.S., Kandasamy S., Siegismund C.S., Saif L.J. Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model. J. Immunol. 2013, 190(May (9)):4742-4753.
427. Wakuda M., Ide T., Sasaki J., Komoto S., Ishii J., Sanekata T., Taniguchi K. Porcine rotavirus closely related to novel group of human rotaviruses. Emerg. Infect. Dis. 2011, 17(August (8)):1491-1493.
428. Wang Y., Azevedo M., Saif L.J., Gentsch J.R., Glass R.I., Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine 2010, 28(July (33)):5432-5436.
429. Wang Y., Dennehy P.H., Keyserling H.L., Tang K., Gentsch J.R., Glass R.I., Jiang B. Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J. Virol. 2007, 81(April (8)):3904-3912.
430. Ward R.L., Knowlton D.R., Pierce M.J. Efficiency of human rotavirus propagation in cell culture. J. Clin. Microbiol. 1984, 19(June (6)):748-753.
431. Ward L.A., Rosen B.I., Yuan L., Saif L.J. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J. Gen. Virol. 1996, 77(July (Pt 7)):1431-1441.
432. Ward R.L., Bernstein D.I., Young E.C., Sherwood J.R., Knowlton D.R., Schiff G.M. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J. Infect. Dis. 1986, 154(November (5)):871-880.
433. Weijer C. The future of research into rotavirus vaccine. BMJ 2000, 321(September (7260)):525-526.
434. Weintraub E.S., Baggs J., Duffy J., Vellozzi C., Belongia E.A., Irving S., Klein N.P., Glanz J.M., Jacobsen S.J., Naleway A., Jackson L.A., DeStefano F. Risk of intussusception after monovalent rotavirus vaccination. N. Engl. J. Med. 2014, 370(February (6)):513-519.
435. Weitkamp J.H., Kallewaard N.L., Bowen A.L., Lafleur B.J., Greenberg H.B., Crowe J.E. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J. Immunol. 2005, 174(March (6)):3454-3460.
436. Wentzel J. Investigating the Importance of Co-expressed Rotavirus Proteins in the Development of a Selection-Free Rotavirus Reverse Genetics System 2014, (PhD thesis), North West University, South Africa.
437. Wentzel J., O'Neill T., van Dijk A. Suppressing the interferon response elicited by rotavirus transcripts using plasmid-derived rotavirus non-structural proteins NSP1, NSP2 and NSP5/6. 5th European Rotavirus Biology Meeting 2013, 51. Abstract book P-05.
438. World Health Organization (WHO) Rotavirus vaccines. WHO position paper - January 2013. Wkly. Epidemiol. Rec. 2013, 88(February (5)):49-64.
439. Yi J., Anderson E.J. Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty. Expert Rev. Vaccines 2013, 12(June (6)):585-587.
440. Yih W.K., Lieu T.A., Kulldorff M., Martin D., McMahill-Walraven C.N., Platt R., Selvam N., Selvan M., Lee G.M., Nguyen M. Intussusception risk after rotavirus vaccination in U.S. infants. N. Engl. J. Med. 2014, 370(February (6)):503-512.
441. Yuan L., Honma S., Ishida S., Yan X.Y., Kapikian A.Z., Hoshino Y. Species-specific but not genotype-specific primary and secondary isotype-specific NSP4 antibody responses in gnotobiotic calves and piglets infected with homologous host bovine (NSP4[A]) or porcine (NSP4[B]) rotavirus. Virology 2004, 330(December (1)):92-104.
442. Yuan L., Saif L.J. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet. Immunol. Immunopathol. 2002, 87(September (3-4)):147-160.
443. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., Podder G., Vu D.T., Le T.P., Luby S.P., Le H.T., Coia M.L., Lewis K., Rivers S.B., Sack D.A., Schödel F., Steele A.D., Neuzil K.M., Ciarlet M. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(August (9741)):615-623.
444. Zárate S., Cuadras M.A., Espinosa R., Romero P., Juárez K.O., Camacho-Nuez M., Arias C.F., López S. Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5. J. Virol. 2003, 77(July (13)):7254-7260.
445. Zárate S., Romero P., Espinosa R., Arias C.F., López S. VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site. J. Virol. 2004, 78(October (20)):10839-10847.
446. Zeng C.Q., Estes M.K., Charpilienne A., Cohen J., The N. terminus of rotavirus VP2 is necessary for encapsidation of VP1 and VP3. J. Virol. 1998, 72(January (1)):201-208.
447. Zeng C.Q., Wentz M.J., Cohen J., Estes M.K., Ramig R.F. Characterization and replicase activity of double-layered and single-layered rotavirus-like particles expressed from baculovirus recombinants. J. Virol. 1996, 70(May (5)):2736-2742.
448. Zhang M., Zeng C.Q., Morris A.P., Estes M.K. A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells. J. Virol. 2000, 74(December (24)):11663-11670.
449. Zhang R., Jha B.K., Ogden K.M., Dong B., Zhao L., Elliott R., Patton J.T., Silverman R.H., Weiss S.R. Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(August (32)):13114-13119.